Has Neil Singhania received payments from drug or device companies?

Yes. Drug and device makers reported $25,520 in general payments to Neil Singhania across 839 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neil Singhania did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neil Singhania come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neil Singhania

Allergy & Immunology · Arlington, TXNPI 1669535886

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $16,589 of the $25,520 with a category attached, or 65.0%. It is spread thinly across 40 manufacturers, the largest accounting for just 19.1%.

$25,520in general payments, 2019–2025

Across 839 payments — averaging $30.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

CSL Behring$5K
GSK$5K
Boehringer Ingelheim$3K
AstraZeneca$2K
Regeneron Healthcare Solutions, Inc.$2K
Kaleo, Inc.$946
plus $8K from 34 others

What the payments were for

Consulting fees$5,79523%
Speaking & faculty fees$2,85511%
Travel & lodging$850%
Food & beverage$16,58965%
Education$1961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
CSL Behring	73	$4,875
GSK	127	$4,529
Boehringer Ingelheim	23	$3,412
AstraZeneca	103	$1,994
Regeneron Healthcare Solutions, Inc.	67	$1,882
Kaleo, Inc.	61	$946
Novartis	43	$913
Takeda Pharmaceuticals U.S.A., Inc.	43	$862
Sanofi	27	$639
Covis Pharma GmbH	37	$631
Genentech USA, Inc.	31	$598
Pfizer	30	$595
Sanofi-aventis U.S. LLC	16	$364
Grifols USA, LLC	15	$349
Optinose US, Inc.	17	$322
Octapharma USA, Inc.	7	$291
Amgen	16	$268
Pharming Healthcare, Inc.	12	$255
Biocryst US Sales Co., LLC	13	$252
Blueprint Medicines Corporation	5	$222
Teva Pharmaceuticals USA, Inc.	11	$171
LEO Pharma Inc.	8	$163
ARS Pharmaceuticals Operations, Inc.	6	$141
Alk-abello, Inc	5	$111
Organon	9	$100
Arcutis Biotherapeutics, Inc.	5	$95
Incyte Corporation	4	$85
Aimmune Therapeutics, Inc.	4	$80
Shire North American Group Inc	5	$73
Azurity Pharmaceuticals, Inc.	3	$61
Hikma Pharmaceuticals USA	3	$49
Merck	2	$41
Biocryst Pharmaceuticals, Inc.	1	$28
Lilly USA, LLC	1	$23
Kedrion Biopharma, Inc.	1	$22
AbbVie	1	$17
Phadia US Inc.	1	$17
Genentech, Inc.	1	$17
Galderma Laboratories, L.p.	1	$14
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Andembry$3,078
NUCALA$2,600
AYVAKIT$122
XOLAIR$120
FASENRA$120
Haegarda$106
DUPIXENT$101

How this compares

$25,520 in reported general payments places this provider in the 85th percentile of 336 allergy & immunology providers in Texas.

See all allergy & immunology providers in Texas →

Other allergy & immunology in Arlington

Joseph DiazSan Antonio$1.1M
Richard WassermanDallas$452K
Matthew FeldmanDallas$410K
Lukena KarkhanisSan Antonio$377K
Paul VigoAustin$304K
Neha ReshamwalaAustin$303K
Lara GrossDallas$171K
Bobby LanierBenbrook$149K
Juan ZambranoHouston$146K
Serge de GolovineBellaire$125K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →